Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
Completing a transaction first proposed in February, Innoviva, Inc. agreed to acquire troubled antibiotics developer Entasis Therapeutics Holdings...






